| Q46611174 | A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors |
| Q34876630 | Fenretinide activates caspases and induces apoptosis in gliomas |
| Q42073904 | Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma |
| Q34548935 | Gene expression profiling reveals Cyp26b1 to be an activin regulated gene involved in ovarian granulosa cell proliferation |
| Q40938112 | Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR). |
| Q46117994 | Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer |
| Q45296870 | Phase II trial of fenretinide in advanced renal carcinoma |
| Q46722973 | Retinamide-induced apoptosis in glioblastomas is associated with down-regulation of Bcl-xL and Bcl-2 proteins |
| Q33944644 | Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells |
| Q58804592 | The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research |